Estimating the prevalence of immunocompromising conditions and primary immunodeficiency disorders in the Chinese population - 04/01/24
Doi : 10.1016/j.jinf.2023.11.001
Tao Chen 1, Hongni Wang 1
Institute of Infectious Disease and Vaccine, School of Public Health, Zhejiang Chinese Medical University, Hangzhou, China
Chuanxi Fu ⁎ 
Institute of Infectious Disease and Vaccine, School of Public Health, Zhejiang Chinese Medical University, Hangzhou, China
∗Correspondence to: Institute of Infectious Disease and Vaccine, School of Public Health, Zhejiang Chinese Medical University, No. 548, Binwen Rd, Hangzhou 310053, China.Institute of Infectious Disease and Vaccine, School of Public Health, Zhejiang Chinese Medical UniversityNo. 548, Binwen RdHangzhou310053China
Highlights |
• | The prevalence of the immunocompromised status was 25.99/1000 in Chinese population. |
• | Approximately 36.69 million Chinese individuals endure immunocompromised status. |
• | The immunocompromised subjects in the elderly are a challenge for public health. |
Plan
© 2023
The British Infection Association. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 88 - N° 1
P. 63-64 - janvier 2024 Retour au numéro
Article précédent
- Did Saint Leonard suffer from Madura foot at the time of death? Infectious disease diagnosis by paleo-proteotyping
- Philippe Charlier, Jean Armengaud
- Impact of the COVID-19 pandemic on incidence and serotype distribution of pneumococcal meningitis – A prospective, nationwide cohort study from the Netherlands
- Fabian D. Liechti, Merijn W. Bijlsma, Matthijs C. Brouwer, Nina M. van Sorge, Diederik van de Beek
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?